This Article  • PDF of this Correction  • Original article  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Ophthalmology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Ophthalmol. 2000;118:488.

In the Clinical Sciences article by Miller et al titled "Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular Degeneration: Results of a Single Treatment in a Phase 1 and 2 Study," published in the September issue of the ARCHIVES (1999;117:1161-1173), journal omission of financial disclosure, properly reported at the time of manuscript submission, occurred in the acknowledgment section on page 1172. The following statement should have appeared in this article: "Drs Sickenberg and Bressler are consultants for CIBA Vision Inc, Duluth, Ga, and QLT Phototherapeutics Inc, Vancouver, British, Columbia." The journal regrets the error.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Macular Translocation With 360{degrees} Retinotomy for Exudative Age-Related Macular Degeneration
Aisenbrey et al.
Arch Ophthalmol 2002;120:451-459.
ABSTRACT | FULL TEXT  

Increasing the Efficiency of Photodynamic Therapy in the Treatment of Subretinal Neovascularization
Jonas and Schmidt-Erfurth
Arch Ophthalmol 2001;119:1086-1086.
FULL TEXT